Mark Martens, MD
Obstetrics & Gynecology · Auburn, NYNPI 1447221510
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Daiichi Sankyo Inc. at 44.1% of the total. Reporting peaked in 2019 at $12,944 and has fallen 96.7% since, to $430 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $543.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$10K
- Astellas Pharma US Inc$6K
- AMAG Pharmaceuticals, Inc.$2K
- Scynexis, Inc.$1K
- Intuitive Surgical$1K
- Gynesonics, Inc.$748
- plus $1K from 8 others
Across 160 payments — averaging $3367.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$244K
- Sanofi Pasteur Inc.$145K
- Pfizer$108K
- Bayer$42K
What the payments were for
- Consulting fees$10,96349%
- Speaking & faculty fees$7,16032%
- Travel & lodging$1,9369%
- Food & beverage$1,7718%
- Education$4592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $9,824 |
| Astellas Pharma US Inc | 4 | $6,178 |
| AMAG Pharmaceuticals, Inc. | 10 | $1,627 |
| Scynexis, Inc. | 3 | $1,366 |
| Intuitive Surgical | 5 | $1,230 |
| Gynesonics, Inc. | 3 | $748 |
| Xellia Pharmaceuticals | 1 | $500 |
| Hologic Sales And Service, LLC | 5 | $468 |
| Sumitomo Pharma America, Inc. | 1 | $143 |
| Pfizer | 2 | $49 |
| Acessa Health Inc. | 1 | $48 |
| Bayer | 1 | $47 |
| Octapharma USA, Inc. | 1 | $41 |
| Shield Therapeutics Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$6,056
- FERAHEME$1,213
- Da Vinci Surgical System$1,203
- Sonata System$579
- MYOSURE TISSUE REMOVAL DEVICE$250
- Sontata System$169
- MYFEMBREE$143
- INTRAROSA$113
How this compares
$22,290 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Auburn
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.